Dr. Seenu Hariprasad from the University of Chicago joins the program to discuss corticosteroids for the treatment of retinal vascular disease including diabetic macular edema, among other topics.
Financial Disclosures: Dr. Sridhar has served as a consultant for Alcon Laboratories and Thrombogenics. Dr. Hariprasad is a consultant or serves on the speaker’s bureau for Clearside Biomedical, EyePoint Pharmaceuticals, Allergan, Alimera Sciences, Alcon Laboratories, OD-OS, Novartis, Spark Therapeutics and Regeneron.